{"id":29101,"date":"2014-08-21T11:25:52","date_gmt":"2014-08-21T15:25:52","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=29101"},"modified":"2014-08-21T11:25:52","modified_gmt":"2014-08-21T15:25:52","slug":"ariad-pharmaceuticals-inc-nasdaqaria-director-alexander-denner-acquires-shares-indirectly","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/ariad-pharmaceuticals-inc-nasdaqaria-director-alexander-denner-acquires-shares-indirectly-29101","title":{"rendered":"Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) Director Alexander Denner Acquires Shares Indirectly"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 08\/21\/2114 (wallstreetpr) \u2013 A global oncology company, <strong>Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)<\/strong> Director Alexander Denner had resorted to buying the company shares from the open market indirectly on August 15. The acquisition of shares was done for Sarissa Capital for two of its funds. Interestingly, the move comes in the wake of a Sell call given by <strong>Citigroup (NYSE:C)<\/strong> recently.<\/p>\n<p style=\"text-align: justify;\"><strong>Buys Shares<\/strong><\/p>\n<p style=\"text-align: justify;\">There were two transactions of buying of shares that had been disclosed to the Securities and Exchange Commission or the <a href=\"http:\/\/www.sec.gov\/Archives\/edgar\/data\/884731\/000112760214025958\/xslF345X01\/form4.xml\" target=\"_blank\">SEC<\/a> through a filing. The company Director Alexander Denner came in the category of 10% owner.<\/p>\n<p style=\"text-align: justify;\">He had acquired 615,466 shares for its Sarissa Capital Domestic Fund LP on August 15 at the rate of $5.83 a share by spending $3.59 million. Following the transaction, the fund would have a total of approximately 7.8 million shares in the Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA).<\/p>\n<p style=\"text-align: justify;\">Similarly, another fund from the same group, Sarissa Capital Offshore Master Fund LP had resorted to buying 234,534 shares at an average price of $5.83 on the same day for approximately $1.37 million. As a result of the transaction, the fund had increased its holding to about 5.05 million shares in the company.<\/p>\n<p style=\"text-align: justify;\"><strong>Price Comparison<\/strong><\/p>\n<p style=\"text-align: justify;\">The purchase price of $5.83 indicates that the fund had paid about 171.2% more than the yearly low price of $2.15. However, they have got the shares at a discount of 74.7% compared to the 52-week high price of $23.<\/p>\n<p style=\"text-align: justify;\">At least two brokerages have reduced their price target on Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares recently. While <a href=\"http:\/\/www.wkrb13.com\/markets\/359098\/insider-buying-ariad-pharmaceuticals-director-alexander-j-denner-buys-850000-shares-of-stock-aria\/\" target=\"_blank\">Citigroup<\/a> had slashed its price objective to $5 from $7, JMP Securities had reduced its price target on the company\u2019s stock to $7 from $8. This meant that the two funds had paid 83 cents more than the Citigroup (NYSE:C)\u2019s revised price objective while they paid $1.17 lower than JMP\u2019s new price tag.<\/p>\n<p style=\"text-align: justify;\"><strong>Consensus Rating<\/strong><\/p>\n<p style=\"text-align: justify;\">While ten analysts\u2019 have preferred to advice investors with a Hold rating, four analysts\u2019 have found the stock to be a fit case for Sale and eight analysts\u2019 rated the stock as a Buy. Therefore, the consensus is in favor Hold with a consensus price tag of $6.75.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 08\/21\/2114 (wallstreetpr) \u2013 A global oncology company, Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) Director Alexander Denner had resorted to buying the company shares from the [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":14450,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[3315,2780,1007,4305,2781,1008],"stock_ticker":[],"class_list":["post-29101","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-ariad-pharmaceuticals-inc","tag-ariad-pharmaceuticals-inc-nasdaqaria","tag-citigroup","tag-citigroup-nysec","tag-nasdaqaria","tag-nysec","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) Director Alexander Denner Acquires Shares Indirectly - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/ariad-pharmaceuticals-inc-nasdaqaria-director-alexander-denner-acquires-shares-indirectly-29101\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) Director Alexander Denner Acquires Shares Indirectly - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 08\/21\/2114 (wallstreetpr) \u2013 A global oncology company, Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) Director Alexander Denner had resorted to buying the company shares from the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/ariad-pharmaceuticals-inc-nasdaqaria-director-alexander-denner-acquires-shares-indirectly-29101\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-08-21T15:25:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Ariad-Pharmaceuticals-Inc.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"709\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Greg Folin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Greg Folin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ariad-pharmaceuticals-inc-nasdaqaria-director-alexander-denner-acquires-shares-indirectly-29101#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ariad-pharmaceuticals-inc-nasdaqaria-director-alexander-denner-acquires-shares-indirectly-29101\"},\"author\":{\"name\":\"Greg Folin\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\"},\"headline\":\"Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) Director Alexander Denner Acquires Shares Indirectly\",\"datePublished\":\"2014-08-21T15:25:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ariad-pharmaceuticals-inc-nasdaqaria-director-alexander-denner-acquires-shares-indirectly-29101\"},\"wordCount\":354,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ariad-pharmaceuticals-inc-nasdaqaria-director-alexander-denner-acquires-shares-indirectly-29101#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Ariad-Pharmaceuticals-Inc.jpg\",\"keywords\":[\"Ariad Pharmaceuticals Inc.\",\"Ariad Pharmaceuticals Inc. (NASDAQ:ARIA)\",\"Citigroup\",\"Citigroup (NYSE:C)\",\"NASDAQ:ARIA\",\"NYSE:C\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/ariad-pharmaceuticals-inc-nasdaqaria-director-alexander-denner-acquires-shares-indirectly-29101#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ariad-pharmaceuticals-inc-nasdaqaria-director-alexander-denner-acquires-shares-indirectly-29101\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ariad-pharmaceuticals-inc-nasdaqaria-director-alexander-denner-acquires-shares-indirectly-29101\",\"name\":\"Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) Director Alexander Denner Acquires Shares Indirectly - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ariad-pharmaceuticals-inc-nasdaqaria-director-alexander-denner-acquires-shares-indirectly-29101#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ariad-pharmaceuticals-inc-nasdaqaria-director-alexander-denner-acquires-shares-indirectly-29101#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Ariad-Pharmaceuticals-Inc.jpg\",\"datePublished\":\"2014-08-21T15:25:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ariad-pharmaceuticals-inc-nasdaqaria-director-alexander-denner-acquires-shares-indirectly-29101#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/ariad-pharmaceuticals-inc-nasdaqaria-director-alexander-denner-acquires-shares-indirectly-29101\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ariad-pharmaceuticals-inc-nasdaqaria-director-alexander-denner-acquires-shares-indirectly-29101#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Ariad-Pharmaceuticals-Inc.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Ariad-Pharmaceuticals-Inc.jpg\",\"width\":1024,\"height\":709},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ariad-pharmaceuticals-inc-nasdaqaria-director-alexander-denner-acquires-shares-indirectly-29101#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) Director Alexander Denner Acquires Shares Indirectly\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\",\"name\":\"Greg Folin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"caption\":\"Greg Folin\"},\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) Director Alexander Denner Acquires Shares Indirectly - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/ariad-pharmaceuticals-inc-nasdaqaria-director-alexander-denner-acquires-shares-indirectly-29101","og_locale":"en_US","og_type":"article","og_title":"Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) Director Alexander Denner Acquires Shares Indirectly - Wall Street PR","og_description":"Boston, MA 08\/21\/2114 (wallstreetpr) \u2013 A global oncology company, Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) Director Alexander Denner had resorted to buying the company shares from the [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/ariad-pharmaceuticals-inc-nasdaqaria-director-alexander-denner-acquires-shares-indirectly-29101","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-08-21T15:25:52+00:00","og_image":[{"width":1024,"height":709,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Ariad-Pharmaceuticals-Inc.jpg","type":"image\/jpeg"}],"author":"Greg Folin","twitter_misc":{"Written by":"Greg Folin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/ariad-pharmaceuticals-inc-nasdaqaria-director-alexander-denner-acquires-shares-indirectly-29101#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/ariad-pharmaceuticals-inc-nasdaqaria-director-alexander-denner-acquires-shares-indirectly-29101"},"author":{"name":"Greg Folin","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e"},"headline":"Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) Director Alexander Denner Acquires Shares Indirectly","datePublished":"2014-08-21T15:25:52+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/ariad-pharmaceuticals-inc-nasdaqaria-director-alexander-denner-acquires-shares-indirectly-29101"},"wordCount":354,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/ariad-pharmaceuticals-inc-nasdaqaria-director-alexander-denner-acquires-shares-indirectly-29101#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Ariad-Pharmaceuticals-Inc.jpg","keywords":["Ariad Pharmaceuticals Inc.","Ariad Pharmaceuticals Inc. (NASDAQ:ARIA)","Citigroup","Citigroup (NYSE:C)","NASDAQ:ARIA","NYSE:C"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/ariad-pharmaceuticals-inc-nasdaqaria-director-alexander-denner-acquires-shares-indirectly-29101#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/ariad-pharmaceuticals-inc-nasdaqaria-director-alexander-denner-acquires-shares-indirectly-29101","url":"https:\/\/cablemanpro.com\/wallstreetpr\/ariad-pharmaceuticals-inc-nasdaqaria-director-alexander-denner-acquires-shares-indirectly-29101","name":"Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) Director Alexander Denner Acquires Shares Indirectly - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/ariad-pharmaceuticals-inc-nasdaqaria-director-alexander-denner-acquires-shares-indirectly-29101#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/ariad-pharmaceuticals-inc-nasdaqaria-director-alexander-denner-acquires-shares-indirectly-29101#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Ariad-Pharmaceuticals-Inc.jpg","datePublished":"2014-08-21T15:25:52+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/ariad-pharmaceuticals-inc-nasdaqaria-director-alexander-denner-acquires-shares-indirectly-29101#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/ariad-pharmaceuticals-inc-nasdaqaria-director-alexander-denner-acquires-shares-indirectly-29101"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/ariad-pharmaceuticals-inc-nasdaqaria-director-alexander-denner-acquires-shares-indirectly-29101#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Ariad-Pharmaceuticals-Inc.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Ariad-Pharmaceuticals-Inc.jpg","width":1024,"height":709},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/ariad-pharmaceuticals-inc-nasdaqaria-director-alexander-denner-acquires-shares-indirectly-29101#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) Director Alexander Denner Acquires Shares Indirectly"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e","name":"Greg Folin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","caption":"Greg Folin"},"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/29101","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=29101"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/29101\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/14450"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=29101"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=29101"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=29101"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=29101"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}